InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Claiborne Cary J. Insider active across 1 company, notably Adial Pharmaceuticals, INC.. In total, 5 disclosures have been recorded. History available since 18 August 2022. The latest transaction was disclosed on 7 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Claiborne Cary J is a declarant linked to Adial Pharmaceuticals, INC., where the listed role is Chief Executive Officer. The record shows 5 filings in total, and across the 5 sampled filings the buy and sell amounts are both 0, with a date range from 2022-08-22 to 2026-04-09. The modal transaction nature is Attribution.